Brief: Nkarta Announces Initiation Of Investigator-Sponsored Clinical Trial Evaluating NKX019 For Systemic Lupus Erythematosus
24/07/2024 11:11
July 24 (Reuters) - Nkarta Inc NKTX.O :
* NKARTA ANNOUNCES INITIATION OF INVESTIGATOR-SPONSORED
CLINICAL
TRIAL EVALUATING NKX019 FOR SYSTEMIC LUPUS ERYTHEMATOSUS
Source text for Eikon: ID:nGNX7GFz1L
Further company coverage: NKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nkarta
See all newsNkarta, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biotech firm Nkarta posts Q2 net loss; cash runway into 2029
Brief: Nkarta Q2 EPS USD -0.54
Nkarta, Inc. expected to post a loss of 38 cents a share - Earnings Preview
Biotech experts want FDA drug reviews based on science, not politics (updated)